FdaApplication

NDA 021630

Back to search

Identifiers

Properties

PropertyValue
applicant_namePF PRISM CV
application_typeNDA
approval_date2003-12-19

Products (1)

ProductActive ingredientStrengthDosage form
VFENDVORICONAZOLE200MG/5MLFOR SUSPENSION;ORAL

1 product